Question 1

How does Crateva nurvala work for kidney stones?

Accepted Answer

Crateva nurvala contains active compounds including lupeol and betulin, which demonstrate anti-lithiatic (stone-preventing) properties. Research suggests these compounds help inhibit calcium oxalate crystal formation, a primary component of most kidney stones. Additionally, the herb exhibits diuretic effects that may help flush existing stones from the urinary tract. The glucosinolates and saponins contribute anti-inflammatory activity, potentially reducing urinary tract irritation. Evidence level: C (preliminary studies and traditional use support these mechanisms, though clinical trials remain limited).

Question 2

Does Crateva nurvala interact with any medications?

Accepted Answer

There are no well-documented drug interactions for Crateva nurvala in current medical literature. However, due to its diuretic properties, it may theoretically enhance the effects of diuretic medications, potentially causing dehydration or electrolyte imbalances. Patients taking lithium should exercise caution, as altered kidney function could affect lithium clearance. Those on blood pressure medications should monitor levels closely. Always consult a healthcare provider before combining herbal supplements with prescription medications.

Question 3

What is the recommended dosage for Crateva nurvala bark extract?

Accepted Answer

The standard adult dosage for Crateva nurvala bark extract is 500-1000mg daily, typically divided into two doses. Traditional Ayurvedic preparations may use decoctions of the bark, though standardized extracts offer more consistent dosing. For urinary stone management, treatment duration may extend several weeks to months under practitioner guidance. Dosage adjustments may be necessary based on individual response and condition severity. Always follow product-specific recommendations or consult a qualified herbalist for personalized dosing.

Question 4

Is Crateva nurvala safe to take during pregnancy?

Accepted Answer

Crateva nurvala is considered unsafe during pregnancy and should be avoided. Traditional Ayurvedic texts and modern safety assessments contraindicate its use in pregnant women. The herb's effects on uterine tissue and potential hormonal interactions pose risks to fetal development. Women who are breastfeeding should also avoid this herb due to insufficient safety data. Those planning pregnancy should discontinue use before conception. Always inform your healthcare provider of any herbal supplements when pregnant or trying to conceive.

Question 5

Can Crateva nurvala help with benign prostatic hyperplasia (BPH)?

Accepted Answer

Crateva nurvala shows promise for managing benign prostatic hyperplasia (BPH) symptoms. Preliminary research suggests the herb may help reduce prostate inflammation and improve urinary flow in men with BPH. The anti-inflammatory compounds, including lupeol, may contribute to prostate tissue health. Traditional Ayurvedic practitioners have long used this herb for urinary difficulties associated with prostate enlargement. Evidence level: C (limited clinical studies exist, though traditional use is well-established). Men with BPH should consult a urologist for proper diagnosis and treatment.

Question 6

What are the side effects of Crateva nurvala?

Accepted Answer

Crateva nurvala is generally well-tolerated when taken at recommended doses. Reported side effects are primarily mild gastrointestinal reactions, including nausea, stomach discomfort, and occasional diarrhea. These effects typically subside as the body adjusts to the herb. No serious adverse events have been documented in traditional use. Individuals with known allergies to plants in the Capparaceae family should avoid this herb. Discontinue use if severe digestive symptoms occur and consult a healthcare provider.

Crateva nurvala

Sources & Citations

Cirsium arvense

Burundian Vernonia

Carya illinoinensis

Summary

Background

Traditional uses

Active compounds

Mechanism of action

Clinical evidence

Safety & adverse effects

Evidence summary

PubMed sources

Government sources